摘要
目的:观察前列腺腔内剜除术治疗良性前列腺增生的安全性与有效性。方法:对80例良性前列腺增生(BPH)患者采用尿道前列腺腔内剜除术进行治疗,回顾性比较手术前后最大尿流率(Qmax)、膀胱剩余尿量(RUV)及国际前列腺症状评分(IPSS)差异。结果:80例患者手术顺利完成,术中未出现大出血、无闭孔神经损伤、术后尿失禁、经尿道电切综合征(TURS)等并发症;随访3~10个月,平均6.5个月,统计术后1周、1个月、3个月IPSS、Qmax、残余尿量,与术前比较,各项指标均有明显改善。结论:经尿道前列腺腔内剜除术(PKEP)治疗良性前列腺增生症具有操作简单、组织损伤小、机体恢复快等优点,是一种安全高效的方法。
Objective: To evaluate the clinical effect of the plasma kinetic enucleation of the prostate ( PKEP ) in treatment of benign prostatic hyperplasia ( BPH ) . Method: 80 patients with benign prostatic hyperplasia ( BPH ) were treated by transurethral enucleation of the prostate. The difference in maximum urinary flow rate ( Qmax ), bladder residual urine volume ( RUV ), and the International Prostate Symptom Score ( IPSS ) was retrospectively compared before and after surgery. Result: 80 patients got successful compli cations. Surgery did not appear intraoperative bleeding, obturator nerve injury, urinary incontinence after transurethral resection complications syndrome ( TURS ) . Followed up for 3 to 10 months , with an average of 6.5 months, statistics after one week, one month, three months, IPSS, Qmax, residual urine volume, numerical comparison with the preoperative indicators showed significant improvement. Conclusion: PKEP is effective in treating BPH. It can completely enucleate the hyperplastic tissue with little bleeding in operation. The treatment has the advantages of short catheter time and significant clinical improvements.
出处
《中国医学创新》
CAS
2013年第11期103-104,共2页
Medical Innovation of China
关键词
前列腺增生症
等离子
前列腺剜除术
Benign prostatic hyperplasia
Transurethral enucleation of the prostate
Transurethral resection of prostate